Format

Send to

Choose Destination
Nephrology (Carlton). 2006 Oct;11(5):405-9.

Regional citrate anticoagulation in continuous venovenous haemofiltration using commercial preparations.

Author information

1
Division of Nephrology, Hypertension and Transplantation, University of Florida, Gainesville, Florida 32610-0224, USA.

Abstract

AIM:

The aim of the present study was to test the feasibility of using commercial preparations of replacement and citrate anticoagulation solution in continuous venovenous haemofiltration (CVVH) in a safe, efficient and simple manner.

METHODS:

Retrospective review of the database of a large continuous renal replacement therapy programme that uses a standardized prescription of high ultrafiltrate CVVH with commercial solutions for replacement fluid and regional citrate anticoagulation was performed.

RESULTS:

Records of 28 patients who underwent 91 CVVH sessions were analysed. Median circuit survival time was 37 (59.5-15.5) h and the 48 h survival probability was 40%. Bleeding or metabolic complications were not noted, and the procedure was simple to administer.

CONCLUSION:

Continuous venovenous haemofiltration using commercial preparations of replacement fluid and citrate anticoagulation can be safe, efficient and simple.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center